News Release
PharmAsia News reported that China might be the third country in the world to have pirfenidone approved for Idiopathic Pulmoary Fibrosis. “In China, IPF is estimated to affect up to about 400,000 to 500,000 patients every year ……Our company
PharmAsia News reported that China might be the third country in the world to have pirfenidone approved for Idiopathic Pulmoary Fibrosis. “In China, IPF is estimated to affect up to about 400,000 to 500,000 patients every year ……Our company